NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $758,000 | -68.0% | 45,687 | -55.3% | 0.02% | -59.0% |
| Q2 2020 | $2,368,000 | +17.6% | 102,235 | -9.3% | 0.06% | +15.1% |
| Q1 2020 | $2,013,000 | -63.2% | 112,756 | -55.5% | 0.05% | -31.2% |
| Q4 2019 | $5,467,000 | +502.1% | 253,258 | +408.1% | 0.08% | +600.0% |
| Q3 2019 | $908,000 | +250.6% | 49,841 | +584.3% | 0.01% | +120.0% |
| Q2 2019 | $259,000 | +14.1% | 7,283 | +7.9% | 0.01% | 0.0% |
| Q1 2019 | $227,000 | -32.2% | 6,751 | -33.8% | 0.01% | -28.6% |
| Q4 2018 | $335,000 | -24.4% | 10,194 | +40.3% | 0.01% | -22.2% |
| Q3 2018 | $443,000 | +18.1% | 7,265 | -5.5% | 0.01% | -10.0% |
| Q2 2018 | $375,000 | -35.2% | 7,685 | +41.1% | 0.01% | -37.5% |
| Q1 2018 | $579,000 | – | 5,447 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |